262 related articles for article (PubMed ID: 12937146)
1. Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice.
Ishizawa T; Sahara N; Ishiguro K; Kersh J; McGowan E; Lewis J; Hutton M; Dickson DW; Yen SH
Am J Pathol; 2003 Sep; 163(3):1057-67. PubMed ID: 12937146
[TBL] [Abstract][Full Text] [Related]
2. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
[TBL] [Abstract][Full Text] [Related]
3. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.
Lewis J; Dickson DW; Lin WL; Chisholm L; Corral A; Jones G; Yen SH; Sahara N; Skipper L; Yager D; Eckman C; Hardy J; Hutton M; McGowan E
Science; 2001 Aug; 293(5534):1487-91. PubMed ID: 11520987
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated p38MAPK specific antibodies cross-react with sarkosyl-insoluble hyperphosphorylated tau proteins.
Sahara N; Vega IE; Ishizawa T; Lewis J; McGowan E; Hutton M; Dickson D; Yen SH
J Neurochem; 2004 Aug; 90(4):829-38. PubMed ID: 15287888
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau.
Lin WL; Lewis J; Yen SH; Hutton M; Dickson DW
J Neurocytol; 2003 Nov; 32(9):1091-105. PubMed ID: 15044841
[TBL] [Abstract][Full Text] [Related]
6. Granulovacuolar degeneration and unfolded protein response in mouse models of tauopathy and Aβ amyloidosis.
Köhler C; Dinekov M; Götz J
Neurobiol Dis; 2014 Nov; 71():169-79. PubMed ID: 25073087
[TBL] [Abstract][Full Text] [Related]
7. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein.
Lewis J; McGowan E; Rockwood J; Melrose H; Nacharaju P; Van Slegtenhorst M; Gwinn-Hardy K; Paul Murphy M; Baker M; Yu X; Duff K; Hardy J; Corral A; Lin WL; Yen SH; Dickson DW; Davies P; Hutton M
Nat Genet; 2000 Aug; 25(4):402-5. PubMed ID: 10932182
[TBL] [Abstract][Full Text] [Related]
8. Active glycogen synthase kinase-3 and tau pathology-related tyrosine phosphorylation in pR5 human tau transgenic mice.
Köhler C; Dinekov M; Götz J
Neurobiol Aging; 2013 May; 34(5):1369-79. PubMed ID: 23294633
[TBL] [Abstract][Full Text] [Related]
9. Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology.
Leroy K; Ando K; Héraud C; Yilmaz Z; Authelet M; Boeynaems JM; Buée L; De Decker R; Brion JP
J Alzheimers Dis; 2010; 19(2):705-19. PubMed ID: 20110614
[TBL] [Abstract][Full Text] [Related]
10. Amyloid β accelerates phosphorylation of tau and neurofibrillary tangle formation in an amyloid precursor protein and tau double-transgenic mouse model.
Seino Y; Kawarabayashi T; Wakasaya Y; Watanabe M; Takamura A; Yamamoto-Watanabe Y; Kurata T; Abe K; Ikeda M; Westaway D; Murakami T; Hyslop PS; Matsubara E; Shoji M
J Neurosci Res; 2010 Dec; 88(16):3547-54. PubMed ID: 20936700
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
12. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.
Koson P; Zilka N; Kovac A; Kovacech B; Korenova M; Filipcik P; Novak M
Eur J Neurosci; 2008 Jul; 28(2):239-46. PubMed ID: 18702695
[TBL] [Abstract][Full Text] [Related]
13. IFN-γ promotes τ phosphorylation without affecting mature tangles.
Li A; Ceballos-Diaz C; DiNunno N; Levites Y; Cruz PE; Lewis J; Golde TE; Chakrabarty P
FASEB J; 2015 Oct; 29(10):4384-98. PubMed ID: 26156074
[TBL] [Abstract][Full Text] [Related]
14. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP
Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173
[TBL] [Abstract][Full Text] [Related]
15. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation.
Pérez M; Ribe E; Rubio A; Lim F; Morán MA; Ramos PG; Ferrer I; Isla MT; Avila J
Neuroscience; 2005; 130(2):339-47. PubMed ID: 15664690
[TBL] [Abstract][Full Text] [Related]
17. Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice.
Leroy K; Bretteville A; Schindowski K; Gilissen E; Authelet M; De Decker R; Yilmaz Z; Buée L; Brion JP
Am J Pathol; 2007 Sep; 171(3):976-92. PubMed ID: 17690183
[TBL] [Abstract][Full Text] [Related]
18. Terminal hypothermic Tau.P301L mice have increased Tau phosphorylation independently of glycogen synthase kinase 3α/β.
Maurin H; Lechat B; Borghgraef P; Devijver H; Jaworski T; Van Leuven F
Eur J Neurosci; 2014 Jul; 40(2):2442-53. PubMed ID: 24754737
[TBL] [Abstract][Full Text] [Related]
19. Tau-tubulin kinase 1 enhances prefibrillar tau aggregation and motor neuron degeneration in P301L FTDP-17 tau-mutant mice.
Xu J; Sato S; Okuyama S; Swan RJ; Jacobsen MT; Strunk E; Ikezu T
FASEB J; 2010 Aug; 24(8):2904-15. PubMed ID: 20354135
[TBL] [Abstract][Full Text] [Related]
20. Tau protein is cross-linked by transglutaminase in P301L tau transgenic mice.
Halverson RA; Lewis J; Frausto S; Hutton M; Muma NA
J Neurosci; 2005 Feb; 25(5):1226-33. PubMed ID: 15689560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]